Polycystic ovary syndrome: Metabolic challenges and new treatment options

  • Gloria A. Bachmann
    Department of Obstetrics, Gynecology, and Reproductive Sciences and Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, and the Division of General Obstetrics and Gynecology, Robert Wood Johnson Medical School. New Brunswick, New Jersey
    Search for articles by this author
      By the year 2000, approximately 50 million women will be postmenopausal. Because of increasing average life expectancy, women can anticipate spending >25 years in the postreproductive state. In light of this scenario, the global problems associated with polycystic ovary syndrome transcend the younger woman’s problems of amenorrhea, irregular menses, infertility, and hirsutism and include potential long-term metabolic and cardiovascular consequences. Long-term consequences of polycystic ovary syndrome are especially important because the problems that stem from android obesity and hyperinsulinemic conditions commence during the reproductive years and persist into the postmenopausal years.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Stein I
        • Leventhal M
        Amenorrhea associated with bilateral polycystic ovaries.
        Am J Obstet Gynecol. 1935; 29: 181-191